MX2019007040A - Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd). - Google Patents

Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd).

Info

Publication number
MX2019007040A
MX2019007040A MX2019007040A MX2019007040A MX2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A MX 2019007040 A MX2019007040 A MX 2019007040A
Authority
MX
Mexico
Prior art keywords
attention deficit
value
methods
disorder
compositions
Prior art date
Application number
MX2019007040A
Other languages
English (en)
Spanish (es)
Inventor
IRANI-COHEN Zackary
LADERMAN Elisabeth
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of MX2019007040A publication Critical patent/MX2019007040A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/305Attention deficit disorder; Hyperactivity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02Food

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2019007040A 2016-12-15 2017-12-15 Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd). MX2019007040A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662434957P 2016-12-15 2016-12-15
PCT/IB2017/058023 WO2018109746A1 (en) 2016-12-15 2017-12-15 Compositions, devices, and methods of attention deficit disorder/ attention deficit hyperactivity disorder (add/adhd) sensitivity testing

Publications (1)

Publication Number Publication Date
MX2019007040A true MX2019007040A (es) 2020-02-12

Family

ID=62558493

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019007040A MX2019007040A (es) 2016-12-15 2017-12-15 Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd).
MX2023005604A MX2023005604A (es) 2016-12-15 2019-06-14 Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd).

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023005604A MX2023005604A (es) 2016-12-15 2019-06-14 Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd).

Country Status (8)

Country Link
US (2) US20200003769A1 (https=)
EP (1) EP3555616B1 (https=)
JP (2) JP2020502510A (https=)
CN (2) CN116047083A (https=)
AU (2) AU2017378442B2 (https=)
CA (1) CA3085431A1 (https=)
MX (2) MX2019007040A (https=)
WO (1) WO2018109746A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102224649B1 (ko) 2014-11-14 2021-03-05 바이오메리카인코포레이티드 Ibs 민감도 테스트 구성, 장치 및 방법
EP3497447B1 (en) 2016-07-08 2024-09-04 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
JP2026049447A (ja) * 2024-09-06 2026-03-18 国立大学法人金沢大学 牛乳アレルギー検査のためのデバイス、キット、及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US7252957B2 (en) * 2004-02-03 2007-08-07 Immunosciences Lab., Inc. Identification of etiology of autism
WO2005078442A1 (en) * 2004-02-10 2005-08-25 Dantini Daniel C Comprehensive food allergy test
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
CN101109750A (zh) * 2007-07-27 2008-01-23 杭州浙大生科生物技术有限公司 食物过敏原特异性IgG ELISA检测试剂盒及其制备方法
US8802056B2 (en) * 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
EP2941259A4 (en) * 2013-01-04 2016-07-27 Second Genome Inc MIKROBIOMMODULATIONSINDEX
KR102224649B1 (ko) * 2014-11-14 2021-03-05 바이오메리카인코포레이티드 Ibs 민감도 테스트 구성, 장치 및 방법
CN105785008A (zh) * 2014-12-23 2016-07-20 北京新华联协和药业有限责任公司 一种食物不耐受检测试剂盒及其制备方法

Also Published As

Publication number Publication date
CN110402390A (zh) 2019-11-01
EP3555616A4 (en) 2020-06-17
US20200003769A1 (en) 2020-01-02
MX2023005604A (es) 2023-05-29
US20260049980A1 (en) 2026-02-19
AU2017378442A1 (en) 2019-07-04
EP3555616C0 (en) 2024-08-14
EP3555616A1 (en) 2019-10-23
JP2022183349A (ja) 2022-12-08
JP7689378B2 (ja) 2025-06-06
WO2018109746A1 (en) 2018-06-21
AU2023200262A1 (en) 2023-02-16
JP2020502510A (ja) 2020-01-23
CN116047083A (zh) 2023-05-02
AU2017378442B2 (en) 2022-10-20
CA3085431A1 (en) 2018-06-21
EP3555616B1 (en) 2024-08-14

Similar Documents

Publication Publication Date Title
MX2021009297A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs.
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
MX2016013959A (es) Aparato y metodo para colorear pelo personalizado.
EP4343788A3 (en) Diagnostic methods
EA201690465A1 (ru) Способ оценки эффектов композиции, содержащей микроорганизмы, на кишечную микробиоту
MX2023005604A (es) Composiciones, dispositivos, y metodos de prueba de sensibilidad para el trastorno de deficit de atencion/trastorno de hiperactividad con deficit de atencion (add/adhd).
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
WO2015193325A3 (en) Ceramides and their use in diagnosing cvd
MX2023005293A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
SG11201900126YA (en) Object selection method and apparatus
MX2023006660A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad a la osteoartritis.
MX2018011166A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia.
AU2016250096A8 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
MX2024000466A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad a la enfermedad de crohn.
MX391844B (es) Metodo y aparato para estimar la cantidad de microorganismos en una unidad taxonomica en una muestra.
MX2018013120A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
MX2019003931A (es) Metodo y sistema de analisis para analizar una muestra.
GB2552271A (en) A method for diagnosing lung cancer
WO2015166353A3 (en) Early detection of preeclampsia
MX2018007566A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con dolor de cabeza por migraña.
MX2018010856A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.
MX2019000143A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a la depresión.
MX2015016721A (es) Metodo de pronostico en cancer de mama.
Uhm et al. The risk factors for IgG hypogammaglobulinemia after allogeneic hematopoietic stem cell transplantation and its impact on transplant outcomes